Icahn begins raising $3 billion to start the hedge fund, Icahn Partners.   September 17, 2004    Icahn discloses he holds an 8. 9% stake in Mylan Laboratories, a pharmaceutical company which is in talks to buy rival King Pharmaceuticals.   October 14, 2004   Icahn files a proxy statement with the SEC, claiming Mylanâ€™s acquisition of King would be too expensive.   